Johnson & Johnson appeals against $2bn talc ruling rejected by Supreme Court
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
© 2024 Insider International Limited, company number 15236286, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian Group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

Johnson & Johnson appeals against $2bn talc ruling rejected by Supreme Court

Bernard Goyder
June 01, 2021
  • X
  • LinkedIn
  • Show more sharing options
  • Copy Link URLCopied!
  • Print
  • X
  • LinkedIn
Talcum powder medical stethecope doctor.jpg

The US Supreme Court has rejected an appeal by Johnson & Johnson over a lower court’s award of $2bn to a group of women who claim to have suffered ovarian cancer as a result of their exposure to talcum powder products.

A jury in Missouri originally awarded the women $4.7bn in compensation and damages in 2018, an award later reduced to $2bn by a state appeals court.

The

Enter your e-mail to claim a free trial:

Uncover exclusive insights tailored for insurance leaders

    • Stay Informed: Access exclusive industry insights
    • Gain a competitive advantage: Hear first about tactical developments
    • Make better decisions: Understand market dynamics in crucial lines of business
Take a free trial Already a subscriber? Login now

Topics

NewsLegalGeneral casualty/GL
BG
Bernard Goyder
Gift this article